Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-07-22), Medifast's 3-1 Month Momentum % is 7.67%.
The industry rank for Medifast's 3-1 Month Momentum % or its related term are showing as below:
FRA:MDF's 3-1 Month Momentum % is ranked better than 71.58% of 95
companies
in the Personal Services industry
Industry Median: -5.72
vs FRA:MDF: 7.67
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Medifast 3-1 Month Momentum % Related Terms
FRA:MDF vs RGS, EVTK, DROR: 3-1 Month Momentum % Comparison
For the Personal Services subindustry, Medifast's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medifast 3-1 Month Momentum % vs Personal Services Industry
For the Personal Services industry and Consumer Cyclical sector, Medifast's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Medifast's 3-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medifast (FRA:MDF) has a 3-1 Month Momentum % of 7.67% as of Jul. 22, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Medifast and its competitors. According to the industry distribution chart, Medifast ranks #27 out of 95 companies in the Personal Services industry, placing it in the top 28.4%.
Is Medifast's 3-1 Month Momentum % too high?
Medifast's current 3-1 Month Momentum % is 7.67%. Based on the distribution chart, Medifast ranks #27 out of 95 companies in the Personal Services industry, which is above the industry midpoint. Overall, Medifast has a GF Score™ of 67/100, reflecting its overall financial health beyond just this single metric.
How does Medifast's 3-1 Month Momentum % compare to RGS and EVTK?
According to the Personal Services industry distribution chart, Medifast ranks #27 out of 95 companies for 3-1 Month Momentum %. This puts Medifast in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Personal Services company?
A good 3-1 Month Momentum % depends on the Personal Services industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Medifast and its competitors. Medifast's current 3-1 Month Momentum % is 7.67%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medifast stock overvalued right now?
Medifast (FRA:MDF) has a current 3-1 Month Momentum % of 7.67%. The stock's GF Value™ is €7.31, compared to a current price of €9.00 — trading 23.1% above its estimated fair value. The current 3-1 Month Momentum % is 7.67%. Medifast's overall GF Score™ is 67/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Medifast (FRA:MDF), the current 3-1 Month Momentum % is 7.67% as of Jul. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medifast (FRA:MDF) Overvalued in 2026?
Based on GuruFocus' analysis, Medifast stock appears to be overvalued.
The current stock price of €9.00 is trading 23.1% above its estimated GF Value™ of €7.31.
Key valuation signals for FRA:MDF:
3-1 Month Momentum %: 7.67%
GF Value™: €7.31 vs. price of €9.00 (23.1% above fair value)
No single metric tells the full story. See the FRA:MDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. The company provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. The company is focused on offering talent to Lifelong Transformation, Making a Healthy Lifestyle Second Nature.
67GF Score
Get the complete analysis for FRA:MDF
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:MDF has been successfully added to your 
